Arcus Biosciences Inc.(RCUS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RCUS Arcus Biosciences Inc.

盘后交易 04-16 16:36:07 EDT

7.85

-0.16

-2.00%

盘后7.85

+0.000.00%

16:05 EDT

最高8.00	最低7.62	成交量88.28万
今开7.90	昨收8.01	日振幅4.74%
总市值8.31亿	流通市值5.17亿	总股本1.06亿
成交额691.07万	换手率1.34%	流通股本6,584万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RCUS","market":"US","secType":"STK","nameCN":"Arcus Biosciences Inc.","latestPrice":7.85,"timestamp":1744833600000,"preClose":8.01,"halted":0,"volume":882763,"hourTrading":{"tag":"盘后","latestPrice":7.85,"preClose":7.85,"latestTime":"16:05 EDT","volume":21829,"amount":171357.65,"timestamp":1744833909795},"delay":0,"floatShares":65839055,"shares":105836364,"eps":-3.140954,"marketStatus":"盘后交易","change":-0.16,"latestTime":"04-16 16:36:07 EDT","open":7.9,"high":8,"low":7.62,"amount":6910665.30114,"amplitude":0.047441,"askPrice":10.43,"askSize":100,"bidPrice":7,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.140954,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1744848000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1521086400000,"exchange":"NYSE","adjPreClose":8.01,"preHourTrading":{"tag":"盘前","latestPrice":7.6,"preClose":8.01,"latestTime":"07:52 EDT","volume":203,"amount":1526.1900325000001,"timestamp":1744804339087},"postHourTrading":{"tag":"盘后","latestPrice":7.85,"preClose":7.85,"latestTime":"16:05 EDT","volume":21829,"amount":171357.65,"timestamp":1744833909795},"volumeRatio":0.623811,"impliedVol":0.7434,"impliedVolPercentile":0.4821},"requestUrl":"/m/hq/s/RCUS","defaultTab":"news","newsList":[{"id":"2527987601","title":"Arcus Biosciences, Inc.盘中异动 早盘股价大跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527987601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527987601?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:53","pubTimestamp":1744638810,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时53分，Arcus Biosciences, Inc.股票出现波动，股价大幅下挫5.53%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Artelo Biosciences, Inc.、Theratechnologies Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Aditxt, Inc.、Artelo Biosciences, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为302.86%、297.24%、141.96%，振幅较大的相关个股有Artelo Biosciences, Inc.、Theratechnologies Inc.、Metsera, Inc.，振幅分别为48.67%、25.77%、23.79%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414215330a6ba2162&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414215330a6ba2162&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2518271566","title":"Arcus Biosciences, Inc.盘中异动 早盘大幅跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518271566?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:23","pubTimestamp":1741616619,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时23分，Arcus Biosciences, Inc.股票出现波动，股价快速下跌5.22%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3406.15%、721.29%、415.10%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc，振幅分别为41.36%、40.24%、39.34%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022233998a2a9f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022233998a2a9f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2516665940","title":"Arcus Biosciences, Inc.盘中异动 临近收盘大幅下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516665940?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:37","pubTimestamp":1741034235,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时37分，Arcus Biosciences, Inc.股票出现波动，股价急速跳水5.05%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Celularity Inc C/Wts 16/07/2026 涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为215.44%、187.68%、163.59%，振幅较大的相关个股有Radiopharm Theranostics Limited、Entero Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为119.50%、70.53%、64.88%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304043715989a60bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304043715989a60bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2516557562","title":"Arcus Biosciences, Inc.2024财年实现净利润-2.83亿美元，同比增加7.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516557562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516557562?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:01","pubTimestamp":1740844883,"startTime":"0","endTime":"0","summary":"3月2日，Arcus Biosciences, Inc.公布财报，公告显示公司2024财年净利润为-2.83亿美元，同比增加7.82%；其中营业收入为2.58亿美元，同比增加120.51%，每股基本收益为-3.14美元。机构评级：截至2025年3月2日，当前有11家机构对Arcus Biosciences, Inc.目标价做出预测，其中目标均价为32.55美元，其中最低目标价为17.00美元，最高目标价为46.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000218a259dd46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000218a259dd46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS"],"gpt_icon":0},{"id":"2514378385","title":"Arcus Biosciences, Inc.盘中异动 早盘股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514378385?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:30","pubTimestamp":1740753029,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时30分，Arcus Biosciences, Inc.股票出现异动，股价大幅上涨5.77%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Virpax Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.、Ensysce Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为480.20%、239.09%、53.23%，振幅较大的相关个股有Tiziana Life Sciences Ltd、Aardvark Therapeutics, Inc.、Lexeo Therapeutics, Inc.，振幅分别为8.85%、6.22%、4.85%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223030abe0e9b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223030abe0e9b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"1156992500","title":"异动解读 | 分析师利好评级和财报数据超预期,Arcus Biosciences盘中大涨13.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156992500","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156992500?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:13","pubTimestamp":1740582780,"startTime":"0","endTime":"0","summary":"今日盘中,Arcus Biosciences大涨13.38%,引发市场高度关注。有消息指出,这次RCUS盘中大涨的主因可能来自以下两方面:首先,券商H.C. Wainwright将该股评级从\"中性\"上调至\"买入\",并将目标价从18美元大幅上调至24美元。该行分析师认为,RCUS的实验性药物casdatifan有望成为治疗一种名为\"透明细胞肾细胞癌\"的肾癌类型的二线疗法,看好其未来前景。其次,RCUS刚刚公布的2025年第四季度财报数据也令投资者振奋。良好的财报数据反映出公司运营情况向好,增强了市场对该股的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 分析师利好评级和财报数据超预期,Arcus Biosciences盘中大涨13.38%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RCUS"],"gpt_icon":0},{"id":"2514856450","title":"Arcus Biosciences, Inc.盘中异动 股价大涨11.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856450?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:33","pubTimestamp":1740580398,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时33分，Arcus Biosciences, Inc.股票出现波动，股价大幅上涨11.23%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Channel Therapeutics Corporation、Nutriband Inc C/Wts 、Immunoprecise Antibodies Ltd.涨幅较大，Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为122.60%、92.20%、74.72%，振幅较大的相关个股有Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.、Organovo Holdings, Inc.，振幅分别为16.86%、14.35%、13.39%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223318a254f703&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223318a254f703&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"1106972136","title":"Arcus Biosciences第四季度每股亏损$(1.03)优于预期$(1.32)，销售额3600万美元优于预期2890万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106972136","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106972136?lang=zh_cn&edition=full","pubTime":"2025-02-26 05:38","pubTimestamp":1740519531,"startTime":"0","endTime":"0","summary":"Arcus Biosciences 报告季度每股亏损$，优于分析师普遍预期的$，涨幅为21.97%。与去年同期每股亏损$相比，亏损减少4.63%。与去年同期销售额3100万美元相比，增长了16.13%。以上内容来自Benzinga Earnings专栏，原文如下：Arcus Biosciences  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 21.97 percent. This is a 4.63 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $36.00 million which beat the analyst consensus estimate of $28.90 million by 24.57 percent.  This is a 16.13 p","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Arcus Biosciences第四季度每股亏损$(1.03)优于预期$(1.32)，销售额3600万美元优于预期2890万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCUS"],"gpt_icon":0},{"id":"2513773346","title":"Arcus Biosciences, Inc.盘中异动 早盘快速下跌5.01%报10.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513773346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513773346?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:27","pubTimestamp":1740410825,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时27分，Arcus Biosciences, Inc.股票出现异动，股价大幅下跌5.01%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为200.89%、84.63%、27.77%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224232706962ea5e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224232706962ea5e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2513296986","title":"Arcus Biosciences, Inc.盘中异动 急速上涨6.04%报11.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513296986?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148289,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Arcus Biosciences, Inc.股票出现波动，股价快速拉升6.04%。截至发稿，该股报11.39美元/股，成交量8.1623万股，换手率0.08%，振幅1.49%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Osr Holdings, Inc.、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为69.26%、61.10%、18.92%，振幅较大的相关个股有Osr Holdings, Inc.、蓝鸟生物、Gain Therapeutics, Inc.，振幅分别为14.17%、11.05%、10.21%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223129a24eb022&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223129a24eb022&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2512485174","title":"Arcus Biosciences, Inc.盘中异动 早盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512485174?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:56","pubTimestamp":1739976976,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时56分，Arcus Biosciences, Inc.股票出现波动，股价快速上涨5.02%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225616abd504ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225616abd504ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2512193702","title":"HC Wainwright & Co.：维持Arcus Biosciences(RCUS.US)评级，由中性调整至中性评级, 目标价由20.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512193702","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512193702?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:22","pubTimestamp":1739902968,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Arcus Biosciences(RCUS.US)评级，由中性调整至中性评级, 目标价由20.00美元调整至18.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19022248243327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RCUS"],"gpt_icon":0},{"id":"2512198711","title":"大摩：维持Arcus Biosciences(RCUS.US)评级，由增持调整至增持评级, 目标价由36.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512198711","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512198711?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:49","pubTimestamp":1739900980,"startTime":"0","endTime":"0","summary":"大摩：维持Arcus Biosciences(RCUS.US)评级，由增持调整至增持评级, 目标价由36.00美元调整至25.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19014948243213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RCUS"],"gpt_icon":0},{"id":"2512116603","title":"Arcus Biosciences, Inc.盘中异动 急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512116603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512116603?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:35","pubTimestamp":1739889324,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时35分，Arcus Biosciences, Inc.股票出现波动，股价大幅下挫5.11%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为284.49%、100.46%、75.52%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Glycomimetics, Inc.，振幅分别为34.04%、22.30%、18.69%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182235259889fd7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182235259889fd7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2511579364","title":"Arcus Biosciences, Inc.盘中异动 下午盘快速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511579364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511579364?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:01","pubTimestamp":1739473310,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时01分，Arcus Biosciences, Inc.股票出现异动，股价快速上涨5.08%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3159.50%、1873.01%、1225.03%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214030150988460a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214030150988460a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2505063857","title":"Arcus Biosciences, Inc.盘中异动 大幅下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505063857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505063857?lang=zh_cn&edition=full","pubTime":"2025-01-23 04:57","pubTimestamp":1737579437,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日04时57分，Arcus Biosciences, Inc.股票出现波动，股价快速下挫5.23%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Nutriband Inc C/Wts 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Nutriband Inc.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为1047.77%、483.96%、107.64%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Immunoprecise Antibodies Ltd.、Eterna Therapeutics Inc.，振幅分别为68.99%、63.37%、63.32%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123045718abb4f2eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123045718abb4f2eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2503640455","title":"Arcus Biosciences, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503640455?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951554,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Arcus Biosciences, Inc.股票出现波动，股价急速拉升5.03%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.07%、54.43%、35.46%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Eterna Therapeutics Inc.，振幅分别为14.29%、12.00%、11.55%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232359604b427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232359604b427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2502892733","title":"Arcus Biosciences, Inc.盘中异动 股价大跌5.16%报14.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502892733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502892733?lang=zh_cn&edition=full","pubTime":"2025-01-11 01:04","pubTimestamp":1736528664,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日01时04分，Arcus Biosciences, Inc.股票出现异动，股价大幅下跌5.16%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.96%。其相关个股中，Conduit Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Omniab Inc C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1215.10%、808.48%、227.68%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.20%、100.85%、64.55%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111010425a21d314e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111010425a21d314e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2501393739","title":"Arcus Biosciences, Inc.盘中异动 下午盘急速拉升5.01%报15.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501393739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501393739?lang=zh_cn&edition=full","pubTime":"2025-01-08 03:04","pubTimestamp":1736276648,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日03时04分，Arcus Biosciences, Inc.股票出现异动，股价急速拉升5.01%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。其相关个股中，Hoth Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Hoth Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Immuneering Corporation较为活跃，换手率分别为5469.60%、434.46%、244.93%，振幅较大的相关个股有Hoth Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为287.95%、131.21%、87.05%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108030408aba21807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108030408aba21807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2494038252","title":"Arcus Biosciences, Inc.盘中异动 急速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494038252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494038252?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:35","pubTimestamp":1735313724,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时35分，Arcus Biosciences, Inc.股票出现异动，股价急速下挫5.12%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Galectin Therapeutics Inc.、Abpro Holdings, Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为103.94%、45.57%、21.23%，振幅较大的相关个股有Galectin Therapeutics Inc.、Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为65.39%、62.45%、58.33%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122723352495ef8475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122723352495ef8475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcusbio.com","stockEarnings":[{"period":"1week","weight":0.1378},{"period":"1month","weight":-0.1424},{"period":"3month","weight":-0.4383},{"period":"6month","weight":-0.5609},{"period":"1year","weight":-0.5083},{"period":"ytd","weight":-0.4621}],"compareEarnings":[{"period":"1week","weight":0.0828},{"period":"1month","weight":-0.0448},{"period":"3month","weight":-0.0931},{"period":"6month","weight":-0.0768},{"period":"1year","weight":0.0657},{"period":"ytd","weight":-0.0827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcus Biosciences, Inc.于2015年4月30日在特拉华州成立。它们是一家临床阶段的生物制药公司，致力于通过利用开发不足的生物机会创造创新的癌症免疫疗法。具体而言，他们针对特征明确的生物学途径，并提供重要的科学数据支持其调节对癌症的免疫反应的重要性，并且无论是在开发中的分子还是在存在具有次优分布的分子。为了利用这些途径，他们建立了强大而高效的发现能力，以创建和优化高度分化的小分子免疫肿瘤产品候选物。自2015年成立以来，他们已经建立了广泛的小分子和抗体产品候选组合，他们计划共同开发内部组合产品。他们已经启动了两项最先进的候选产品的临床试验，这两种产品预计将在2018年产生数据，并且他们预计在2019年上半年将从他们的第一批产品组合中获得临床数据。他们计划推出两种附加产品候选人到2018年底进入临床试验阶段。Arcus团队的成员共同工作了10多年，在Tularik Inc.，Amgen，Inc.和Flexus Biosciences，Inc.等公司中发现创新的小分子产品候选人。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.054651},{"month":2,"riseRate":0.714286,"avgChangeRate":0.152206},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.096356},{"month":4,"riseRate":0.375,"avgChangeRate":0.055177},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.033648},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.008856},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.000458},{"month":8,"riseRate":0.571429,"avgChangeRate":0.047883},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.013729},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.047954},{"month":11,"riseRate":0.857143,"avgChangeRate":0.156684},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.019666}],"exchange":"NYSE","name":"Arcus Biosciences Inc.","nameEN":"Arcus Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcus Biosciences Inc.(RCUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arcus Biosciences Inc.(RCUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arcus Biosciences Inc.,RCUS,Arcus Biosciences Inc.股票,Arcus Biosciences Inc.股票老虎,Arcus Biosciences Inc.股票老虎国际,Arcus Biosciences Inc.行情,Arcus Biosciences Inc.股票行情,Arcus Biosciences Inc.股价,Arcus Biosciences Inc.股市,Arcus Biosciences Inc.股票价格,Arcus Biosciences Inc.股票交易,Arcus Biosciences Inc.股票购买,Arcus Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcus Biosciences Inc.(RCUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arcus Biosciences Inc.(RCUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}